Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Willamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324.
Article CAS PubMed Google Scholar
Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M, Bravi V, Bendini MG, Mazza A. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40(12):947–63.
Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9(1):80–93.
Article PubMed PubMed Central Google Scholar
Zhang Y, Hou L-S, Tang W-W, Xu F, Xu R-H, Liu X, Liu Y, Liu J-X, Yi Y-J, Hu TS, Hu R, Wang T-D, Haung X-B. High prevalence of obesity-related hypertension among adults aged 40 to 79 years in Southwest China. Sci Rep. 2019;9(1):15838.
Article PubMed PubMed Central ADS Google Scholar
Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic nervous system dysfunction: JACC focus seminar. J Am Coll Cardiol. 2019;73(10):1189–206.
Article PubMed PubMed Central Google Scholar
Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM. The role of the autonomic nervous system in the pathophysiology of obesity. Front Physiol. 2017;8:665.
Article PubMed PubMed Central Google Scholar
Ren J, Zhang Y. Chapter 10—autophagy as a therapeutic target for cardiovascular complications in obesity—concepts, controversies, and challenges. In: Ren J, Sowers JR, Zhang Y, editors. Autophagy and cardiometabolic diseases. Academic Press: Hoboken; 2018. p. 117–26.
Oliveira C, Silveira EA, Rosa L, Santos A, Rodrigues AP, Mendonça C, Silva L, Rodrigues AP, Gentil P, Rebelo AC. Risk factors associated with cardiac autonomic modulation in obese individuals. J Obes. 2020;2020:7185249.
Article PubMed PubMed Central Google Scholar
Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23(11):1170–8.
Article CAS PubMed Google Scholar
Sharma RK, Bhatt A, Dwivedi SK. Effect of obesity on autonomic functions of Heart among healthy volunteers at a teaching Institute. J Family Med Prim Care. 2022;11(7):3636–41.
Article PubMed PubMed Central Google Scholar
Saladini F, Di-Marco A, Palatini P. Autonomic dysfunction: how to identify and when to treat? High Blood Press Cardiovasc Prev. 2016;23(3):237–43.
Bell BB, Rahmouni K. Leptin as a mediator of obesity-induced hypertension. Curr Obes Rep. 2016;5(4):397–404.
Article PubMed PubMed Central Google Scholar
Zorena K, Jachimowicz-Duda O, Ślęzak D, Robakowska M, Mrugacz M. Adipokines and obesity. Potential link to metabolic disorders and chronic complications. Int J Mol Sci. 2020;21:10.
Landecho MF, Tuero C, Valentí V, Bilbao I, de la Higuera M, Frühbeck G. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk. Nutrients. 2019;11:11.
Ghantous CM, Azrak Z, Hanache S, Abou-Kheir W, Zeidan A. Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol. 2015;2015:534320.
Article CAS PubMed PubMed Central Google Scholar
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.
Article CAS PubMed PubMed Central Google Scholar
Cabandugama PK, Gardner MJ, Sowers JR. The renin angiotensin aldosterone system in obesity and hypertension: roles in the cardiorenal metabolic syndrome. Med Clin North Am. 2017;101(1):129–37.
Article PubMed PubMed Central Google Scholar
Battineni G, Sagaro GG, Chintalapudi N, Amenta F, Tomassoni D, Tayebati SK. Impact of obesity-induced inflammation on cardiovascular diseases (CVD). Int J Mol Sci. 2021;22:9.
Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med (Lausanne). 2021;8:798958.
Valensi P. Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications. Cardiovasc Diabetol. 2021;20(1):170.
Article PubMed PubMed Central Google Scholar
Huang X, Qin C, Guo X, Cao F, Tang C. Association of hemoglobin A1c with the incidence of hypertension: a large prospective study. Front Endocrinol (Lausansne). 2022;13:1098012.
Kotsis V, Antza C, Doundoulakis G, Stabouli S. Obesity, hypertension, and dyslipidemia. In: Sbraccia P, Finer N, editors. Obesity: pathogenesis, diagnosis, and treatment. Cham: Springer International Publishing; 2017. p. 1–15.
Paniagua L, Lohsoonthorn V, Lertmaharit S, Jiamjarasrangsi W, Williams MA. Comparison of waist circumference, body mass index, percent body fat and other measure of adiposity in identifying cardiovascular disease risks among thai adults. Obes Res Clin Pract. 2008;2(3):215–23.
Article PubMed PubMed Central Google Scholar
Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev. 2011;12(9):680–7.
Article CAS PubMed PubMed Central Google Scholar
Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):345–51.
Article CAS PubMed PubMed Central Google Scholar
Selvaraj S, Martinez EE, Aguilar FG, Kim KY, Peng J, Sha J, Irvin MR, Lewis CE, Hunt SC, Arnett DK, Shah S. Association of central adiposity with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network study. Circ Cardiovasc Imaging. 2016;9:6.
Moodithaya S, Avadhany ST. Gender differences in age-related changes in cardiac autonomic nervous function. J Aging Res. 2012;2012:679345.
Solaro N, Pagani M, Lucini D. Altered cardiac autonomic regulation in overweight and obese subjects: the role of age-and-gender-adjusted statistical indicators of heart rate variability and cardiac baroreflex. Front Physiol. 2021;11:567312.
Article PubMed PubMed Central Google Scholar
Carthy ER. Autonomic dysfunction in essential hypertension: a systematic review. Anna Med Surg. 2014;3(1):2–7.
Grassi G. Sympathomodulatory effects of antihypertensive drug treatment. Am J Hypertens. 2016;29(6):665–75.
Article CAS PubMed Google Scholar
Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387–97.
Matta M, Pavy-Le Traon A, Perez-Lloret S, Laporte C, Berdugo I, Nasr N, Hanaire H, Senard JM. Predictors of cardiovascular autonomic neuropathy onset and progression in a cohort of type 1 diabetic patients. J Diabetes Res. 2018;2018:5601351.
Article CAS PubMed PubMed Central Google Scholar
Liao D, Rodríguez-Colón SM, He F, Bixler EO. Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality. Curr Treat Options Cardiovasc Med. 2014;16(10):342.
Article PubMed PubMed Central Google Scholar
Williams SM, Eleftheriadou A, Alam U, Cuthbertson DJ, Wilding JPH. Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: a narrative review. Diabetes Ther. 2019;10(6):1995–2021.
Article PubMed PubMed Central Google Scholar
Troutt MD. Regression, 10k Rule of Thumb for. Encyclopedia of statistical sciences.
Austin PC, Steyerberg EW. Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models. Stat Methods Med Res. 2017;26(2):796–808.
Article MathSciNet PubMed Google Scholar
Pavlou M, Ambler G, Seaman S, De Iorio M, Omar RZ. Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. Stat Med. 2016;35(7):1159–77.
Article MathSciNet PubMed Google Scholar
Austin PC, Allignol A, Fine JP. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model. J Clin Epidemiol. 2017;83:75–84.
Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in obesity, inflammation, and cancer. Diabetes Metab J. 2021;45(3):285–311.
Comments (0)